Innate Pharma SA Provisions
Innate Pharma SA (IPHA) had Provisions of EUR 3.81 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes
ifrs-full:Provisions · last filed 2026-04-01
- 2025-12-31: Provisions 3.81M EUR.
- 2025-06-30: Provisions 1.57M EUR.
- 2024-12-31: Provisions 481.00K EUR.
- 2024-06-30: Provisions 669.00K EUR.
| Period end | Provisions |
|---|---|
| 2025-12-31 | 3.81M EUR 20-F · filed 2026-04-01 |
| 2025-06-30 | 1.57M EUR 6-K · filed 2025-09-17 |
| 2024-12-31 | 481.00K EUR 20-F · filed 2026-04-01 |
| 2024-06-30 | 669.00K EUR 6-K · filed 2024-09-12 |
| 2023-12-31 | 774.00K EUR 20-F · filed 2026-04-01 |
| 2023-06-30 | 2.25M EUR 6-K · filed 2023-09-14 |
| 2022-12-31 | 1.74M EUR 20-F · filed 2025-04-30 |
| 2022-06-30 | 1.03M EUR 6-K · filed 2022-09-15 |
| 2021-12-31 | 900.00K EUR 20-F · filed 2024-04-04 |
| 2021-06-30 | 5.85M EUR 6-K · filed 2021-09-15 |
| 2020-12-31 | 897.00K EUR 20-F · filed 2023-04-06 |
| 2019-12-31 | 256.00K EUR 20-F · filed 2022-04-04 |
| 2018-12-31 | 690.00K EUR 20-F · filed 2021-04-27 |
| 2017-12-31 | 1.01M EUR 20-F · filed 2020-04-24 |